Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00976079 · ClinicalTrials.gov registry record · NA
The Effect of Transcutaneous Electrical Nerve Stimulation on Quadriceps Central Activation and Gait
A NA study of Osteoarthritis and Tibial Femoral Knee Osteoarthritis, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
- 1
- Study location
NCT00976079: Completed NA study of Osteoarthritis and Tibial Femoral Knee Osteoarthritis, sponsored by University of Virginia.
NCT00976079 is a NA study of Osteoarthritis and Tibial Femoral Knee Osteoarthritis that has completed, run by University of Virginia. The registered enrollment target is 49 participants, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00976079, a NA study of Osteoarthritis and Tibial Femoral Knee Osteoarthritis, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
- 1
- Study location
Study Summary
Participants diagnosed with tibial femoral knee osteoarthritis will be assigned to one of three treatment groups including: active transcutaneous electrical nerve stimulation (TENS), placebo TENS, and a control group. Assignment of conditions will be concealed. All participants in each of the three groups will receive physical therapy for all 4 weeks of the intervention. Main outcome measures will include quadriceps central activation ratio, quadriceps torque production, WOMAC scores, visual analog pain scores during gait as well as knee joint kinetics and kinematics during gait. The purpose of this study is to to determine if the continuous use of TENS therapy for activities of daily living and rehabilitation will positively impact all outcome measures.
Conditions Studied
Interventions
- DEVICE Transcutaneous electrical nerve stimulation (TENS)
- DEVICE Placebo TENS
Study Locations (1)
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2007-11 |
| Est. Completion | 2009-08 |
| Phase | NA |
What the finished NCT00976079 record still lists
NCT00976079 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 49 participants, a relatively small participant target, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which Transcutaneous electrical nerve stimulation (TENS) is the first listed.
NCT00976079 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT00976079 about?
NCT00976079 is a clinical study titled "The Effect of Transcutaneous Electrical Nerve Stimulation on Quadriceps Central Activation and Gait". Participants diagnosed with tibial femoral knee osteoarthritis will be assigned to one of three treatment groups including: active transcutaneous electrical nerve stimulation (TENS), placebo TENS, and a control group. Assignment of conditions will be concealed. All participants in each of the three ...
What is the current status of trial NCT00976079?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2007-11. Estimated completion is 2009-08.
What conditions does trial NCT00976079 study?
This clinical trial studies the following conditions: Osteoarthritis, Tibial Femoral Knee Osteoarthritis.
What interventions are being tested in trial NCT00976079?
The interventions under investigation include: Transcutaneous electrical nerve stimulation (TENS) (DEVICE), Placebo TENS (DEVICE).
Who is sponsoring clinical trial NCT00976079?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00976079 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00976079's enrollment target sits among peer trials
49 119th of 135 higher than 17 of 135 other Osteoarthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
The PROACTIVE Study for Black Elders
RECRUITING · NA
-
Trans-arterial Embolization for the Treatment of Facet Pain Due to Facet Arthropathy
RECRUITING · NA
-
Dose Response of Exercise for Arthritis Management
RECRUITING · NA
-
Conversations in Health Literacy Using AI Technology for Osteoarthritis Patients
RECRUITING · NA
-
Activating SilverSneakers Benefits for Seniors With Osteoarthritis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia